Charles F. Craddock
Experienced in Chronic Myelomonocytic Leukemia (CMML)

Charles F. Craddock

Coventry, ENG, GB 
Experienced in Chronic Myelomonocytic Leukemia (CMML)
Coventry, ENG, GB 
OverviewLocationsClinical Research

Overview

Charles Craddock practices in Coventry, United Kingdom. Mr. Craddock is rated as an Experienced expert by MediFind in the treatment of Chronic Myelomonocytic Leukemia (CMML). His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Bone Graft.

His clinical research consists of co-authoring 180 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Chronic Myelomonocytic Leukemia (CMML).

Gender
Male

Locations

Coventry, ENG, United Kingdom
Other Locations
Warwick, ENG, United Kingdom
Birmingham, ENG, United Kingdom
Cardiff, WLS, United Kingdom
London, ENG RM70AG, United Kingdom
Sutton Coldfield, ENG, United Kingdom
Gordon, SCT AB107BQ, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Double-Blind, Phase III, Randomised Study to Compare the Efficacy and Safety of Oral Azacitidine (CC-486) Versus Placebo in Subjects With Acute Myeloid Leukaemia or Myelodysplastic Syndromes as Maintenance After Allogeneic Haematopoietic Stem Cell Transplantation
A Double-Blind, Phase III, Randomised Study to Compare the Efficacy and Safety of Oral Azacitidine (CC-486) Versus Placebo in Subjects With Acute Myeloid Leukaemia or Myelodysplastic Syndromes as Maintenance After Allogeneic Haematopoietic Stem Cell Transplantation
Enrollment Status: Active_not_recruiting
Publish Date: May 14, 2024
Intervention Type: Drug
Study Drug: Azacitidine
Study Phase: Phase 3
An International Randomised Clinical Trial of Therapeutic Interventions to Assess the Effects on Outcome in Adults With Acute Myeloid Leukaemia and High Risk Myelodysplasia Undergoing Allogeneic Stem Cell Transplantation.
An International Randomised Clinical Trial of Therapeutic Interventions to Assess the Effects on Outcome in Adults With Acute Myeloid Leukaemia and High Risk Myelodysplasia Undergoing Allogeneic Stem Cell Transplantation.
Enrollment Status: Unknown
Publish Date: May 10, 2023
Intervention Type: Drug
Study Drugs: Vyxeos, Fludarabine, Busulfan, Thiotepa, Cytarabine
Study Phase: Phase 2/Phase 3
View 1 Less Clinical Trial

180 Total Publications

Guidance for JCO Authors on Subgroup Representation and Reporting.
Guidance for JCO Authors on Subgroup Representation and Reporting.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Craddock's expertise for a condition
ConditionClose
View All 16 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile